Akari Therapeutics (AKTX) Profit After Tax Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.88% |
| Dec 31, 2025 | 4.90% |
| Sep 30, 2025 | -55.21% |
| Jun 30, 2025 | 23.93% |
| Mar 31, 2025 | 93.70% |
| Dec 31, 2024 | -78.02% |
| Sep 30, 2024 | -0.09% |
| Jun 30, 2024 | -4.91% |
| Mar 31, 2024 | -33.16% |
| Dec 31, 2023 | -3.33% |
| Sep 30, 2023 | 4.39% |
| Jun 30, 2023 | 12.99% |
| Mar 31, 2023 | 22.40% |
| Jun 30, 2022 | -77.76% |
| Mar 31, 2022 | 16.28% |
| Dec 31, 2021 | 27.75% |
| Sep 30, 2021 | -28.26% |
| Jun 30, 2021 | 7.60% |
| Mar 31, 2021 | -14.36% |
| Dec 31, 2020 | -25.00% |
| Sep 30, 2020 | 15.08% |
| Jun 30, 2020 | -40.88% |
| Mar 31, 2020 | -1,756.84% |
| Dec 31, 2019 | -47.70% |
| Sep 30, 2019 | -66.81% |
| Jun 30, 2019 | -21.69% |
| Mar 31, 2019 | 28.20% |